Electrically evoked hearing perception by functional neurostimulation of the central auditory system.
Perceptional benefits and potential risks of electrical stimulation of the central auditory system are constantly changing due to ongoing developments and technical modifications. Therefore, we would like to introduce current treatment protocols and strategies that might have an impact on functional results of auditory brainstem implants (ABI) in profoundly deaf patients. Patients with bilateral tumours as a result of neurofibromatosis type 2 with complete dysfunction of the eighth cranial nerves are the most frequent candidates for auditory brainstem implants. Worldwide, about 300 patients have already received an ABI through a translabyrinthine or suboccipital approach supported by multimodality electrophysiological monitoring. Patient selection is based on disease course, clinical signs, audiological, radiological and psycho-social criteria. The ABI provides the patients with access to auditory information such as environmental sound awareness together with distinct hearing cues in speech. In addition, this device markedly improves speech reception in combination with lip-reading. Nonetheless, there is only limited open-set speech understanding. Results of hearing function are correlated with electrode design, number of activated electrodes, speech processing strategies, duration of pre-existing deafness and extent of brainstem deformation. Functional neurostimulation of the central auditory system by a brainstem implant is a safe and beneficial procedure, which may considerably improve the quality of life in patients suffering from deafness due to bilateral retrocochlear lesions. The auditory outcome may be improved by a new generation of microelectrodes capable of penetrating the surface of the brainstem to access more directly the auditory neurons.
Department of Neurosurgery, Eberhard-Karls-University, Tuebingen, Germany. marcos.tatagiba@med.uni-tuebingen.de
M
M
Tatagiba
A
A
Gharabaghi
D001307:Auditory Perception; D002986:Clinical Trials as Topic; D017626:Cochlear Nucleus / Q000503:physiopathology*; D046690:Deep Brain Stimulation / Q000379:methods*; D004567:Electrodes, Implanted; D005072:Evoked Potentials, Auditory; D006319:Hearing Loss, Sensorineural / Q000503:physiopathology* / Q000534:rehabilitation*; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D016896:Treatment Outcome